Formulation for soft anticholinergic analogs
US12156865B2 · kind B2 · utility
0Cited by
25References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 20, 2021 |
| Grant date | Dec 3, 2024 |
| Priority date | — |
| Expiry date | Apr 3, 2042 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Topical formulations comprising soft glycopyrrolates are useful for treating excessive sweating conditions in subjects, such as humans suffering from hyperhidrosis. Preferably, at least one soft anticholinergic agent is provided in an effective amount or concentration in an anhydrous formulation that can inhibit excessive perspiration resulting from a condition such as hyperhidrosis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.